An immunofluorescence assay was performed to evaluate the expression level of the transcription factor E2F1 using formalin-fixed, paraffin-embedded, NB primary samples (4-μm thick) from an independent cohort of 38 patients with Stage 4S NB. Here, E2F1 is linked to neuroblastoma.